Showing 1581-1590 of 2526 results for "".
- Reed Exhibitions Unveils New Brand Identityhttps://modernod.com/news/reed-exhibitions-unveils-new-brand-identity/2479287/Reed Exhibitions announced its evolution to RX, with a refreshed visual identity and updated brand positioning, according to The Vision Council. Building on its flagship events business, the company is leveraging its capabilities in data and technology to create
- Johnson & Johnson Vision Expands “Sight For Kids” Program and Unveils “Vision for Good” Community Impact Reporthttps://modernod.com/news/johnson-johnson-vision-expands-sight-for-kids-program-and-unveils-vision-for-good-community-impact-report/2479256/Johnson & Johnson Vision announced the expansion of nonprofit program
- Novartis’ Sandoz Unit Confirms Late-Stage Clinical Development Plans for Proposed Biosimilar Aflibercepthttps://modernod.com/news/novartis-sandoz-unit-confirms-late-stage-clinical-development-plans-for-proposed-biosimilar-aflibercept/2479166/Sandoz, a division of Novartis, announced progress in the late-stage clinical development program for its proposed biosimilar aflibercept. Sandoz will begin enrolling the first patient in MYLIGHT, a clinical phase 3 confirmatory efficacy and safety study, shortly.1 Aflibercept (
- Pfizer, BioNTech Initiate Study of COVID-19 Vaccine in Children Under 12https://modernod.com/news/pfizer-biontech-initiate-study-of-covid-19-vaccine-in-children-under-12/2479017/Pfizer and BioNTech said Thursday that they have started testing their COVID-19 vaccine BNT162b2 in children ages 6 months to 11 years old, with initial results expected in the second half of the year. The mRNA-based vaccine is currently authorized for people 16 years and older in multiple market
- Rabb-Venable Excellence in Ophthalmology Program Abstract Submission Open Until March 31https://modernod.com/news/rabb-venable-excellence-in-ophthalmology-program-abstract-submission-open-until-march-31/2478981/Each year, the National Medical Association–Ophthalmology Section sponsors the Rabb-Venable Excellence in Ophthalmology Program, which is committed to increasing diversity in eye care to better reflect the U.S. population. The Rabb-Venable Program encourages and fosters interest in ophthal
- Focus Vitamins Unveils New Blue Light Product to Help Protect Eyes from Digital Devices and Eye Fatiguehttps://modernod.com/news/focus-vitamins-unveils-new-blue-light-product-to-help-protect-eyes-from-digital-devices-and-eye-fatigue/2478855/Covalent Medical, owner of the brand “Focus Vitamins,” announced today that their new Blue Light mango-flavored gummy will be available to their partner physician practices for resale. “The B.L.U.E. study shows using electronic digital devices can cause eye fatigue, and even interrupt slee
- Turn Biotechnologies Expands the Potential of its mRNA Platform by Licensing Unique Artificial Niche Technologyhttps://modernod.com/news/turn-biotechnologies-expands-the-potential-of-its-mrna-platform-by-licensing-unique-artificial-niche-technology/2478826/Turn Biotechnologies announced that it has acquired the global rights for new artificial niche (AN) technology that can be used to restore muscle stem cells damaged by aging. Terms of the deal were not disclosed. The company licensed its AN technology from Stanf
- Influence of Patient Mask Wearing on Ocular Injection-Related Infection Unclearhttps://modernod.com/news/influence-of-patient-mask-wearing-on-ocular-injection-related-infection-unclear/2478807/Pre-pandemic research suggests that mask wearing by clinicians may reduce infectious endophthalmitis in patients receiving ocular injections, and that a no-talking policy can also help. But the influence of mask wearing by patients themselves still remains to be precisely defined, ressearchers sa
- Sources: FDA Veteran Woodcock Being Considered to Lead Agency Under Bidenhttps://modernod.com/news/sources-fda-veteran-woodcock-being-considered-to-lead-agency-under-biden/2478764/Janet Woodcock, a 30-year veteran of the Food and Drug Administration, is being considered by President-elect Joe Biden to serve as commissioner of the agency, Bloomberg reported,
- Most Doses of Lilly, Regeneron’s COVID-19 Antibody Treatments Are Going Unusedhttps://modernod.com/news/most-doses-of-lilly-regenerons-covid-19-antibody-treatments-are-going-unused/2478665/Moncef Slaoui, chief scientific advisor to the US government’s Operation Warp Speed program, estimates that only 5% to 20% of the roughly 65,000 doses of COVID-19 antibody treatments shipped to states around the country every week end up going to patients. He suggested this was disappointin